Skip to main content
. 2015 Jun 16;15:51. doi: 10.1186/s12872-015-0042-0

Table 1.

Clinical features, risk factors, and laboratory data of the cohort

Characteristics All cohort (n = 220) AMI cases (n = 110) Control cases (n = 110) P
STEMI (n = 65) NSTEMI (n = 45)
Age (years) 57.99 ± 11.63 57.54 ± 12.07 57.93 ± 11.98 58.28 ± 11.32 0.712
Men/women (n/n) 170/50 51/14 36/9 83/27 0.520
Risk factors
Hypertension (Y/N) 103/117 34/31 17/28 52/58 0.893
Hyperlipidemia (Y/N) 26/119 9/56 3/42 14/96 0.676
Diabetes mellitus (Y/N) 50/170 13/52 10/35 27/83 0.520
Smoking (Y/N) 47/173 15/50 8/37 24/86 0.869
Physical examination
SBP (mmHg) 124.64 ± 18.89 125.88 ± 21.51 121.76 ± 16.35 124.23 ± 20.26 0.754
DBP (mmHg) 75.95 ± 11.58 76.68 ± 13.70 73.31 ± 9.60 77.30 ± 10.68 0.132
Heart rate (beats/ min) 74.10 ± 12.98 74.20 ± 13.03 75.38 ± 11.54 73.53 ± 13.57 0.511
Lab examination
TC (mmol/L) 3.9232 ± 0.99 3.91 ± 1.07 3.92 ± 1.09 3.90 ± 0.91 0.998
TG (mmol/L) 1.3727 ± 0.80 1.48 ± 1.17 1.39 ± 0.88 1.30 ± 0.42 0.197
HDL (mmol/L) 1.0470 ± 0.22 0.98 ± 0.23 1.05 ± 0.27 1.09 ± 0.18 0.080
LDL (mmol/L) 2.5300 ± 1.00 2.52 ± 0.97 2.43 ± 0.87 2.58 ± 1.08 0.504
WBC (×109/L) 8.589 ± 3.62 9.51 ± 4.13 10.02 ± 4.01 7.46 ± 2.68 <0.001
BUN (mmol/L) 5.9365 ± 2.73 6.25 ± 3.05 6.16 ± 2.64 5.66 ± 2.55 0.135
CK-MB (U/L) 35.68 ± 59.13 58.80 ± 90.75 48.46 ± 58.17 16.79 ± 8.63 <0.001
Cardiac troponin T (ng/mL) 0.68 ± 1.40 1.44 ± 1.89 1.16 ± 1.57 0.05 ± 0.12 <0.001
EF% 58.14 ± 7.83 56.35 ± 7.89 55.80 ± 8.28 60.15 ± 7.13 <0.001

Abbreviations: AMI acute myocardial infarction, STEMI ST-segment-elevation myocardial infarction, NSTEMI non-ST-segment elevation myocardial infarction, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, TG total triglyceride, HDL high-density lipoprotein, LDL low-density lipoprotein, WBC white blood cell, BUN blood urea nitrogen, CK-MB creatine kinase-MB, EF ejection fractions

Data are expressed as mean ± standard deviation. P: comparison between AMI patients with healthy controls